Literature DB >> 6946981

Hodgkin and sternberg-reed cell antigen(s) detected by an antiserum to a cell line (L428) derived from Hodgkin's disease.

H Stein, J Gerdes, H Kirchner, M Schaadt, V Diehl.   

Abstract

Antisera to the cell line L428, derived from Hodgkin's disease, were raised in rabbits by injecting L428 cells intravenously and subcutaneously. The anti-L428 cell serum that did not react with HLA-DR was absorbed with tonsil cell plus acute myeloid leukemia cells or tonsil cells plus neutrophils, monocytes, and blood lymphocytes. Then it was tested for its ability to discriminate between L428 cells, Hodgkin and Sternberg-Reed cells, and various other cells. It was found that the anti L428 cell serum absorbed with tonsil cells plus acute myeloid leukemia cells stained only L428 cells, Hodgkin and Sternberg-Reed cells, and neutrophils. The anti L428 cell serum absorbed with tonsil cell plus neutrophils, monocytes, and blood lymphocytes reacted with L428 cells and Hodgkin and sternberg-Reed cells from 13 cases of Hodgkin's disease. It did not react with any other cell type present in the blood or in lymphoid tissue or with cells from five cases of non-Hodgkin's lymphoma. The absorbed anti-L428 cell serum also failed to stain Daudi and HRIK cell line cells. We conclude that the anti-L428 cell serum defines an antigen that is apparently restricted in expression to L428 cells and Hodgkin and Sternberg-Reed cells. This is a strong indication that the L428 cell line cells are derived from Hodgkin and Sternberg-Reed cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6946981     DOI: 10.1002/ijc.2910280406

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Granulocyte and HLA-D region specific monoclonal antibodies in the diagnosis of Hodgkin's disease.

Authors:  A J Norton; P G Isaacson
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

2.  Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status.

Authors:  J R Flavell; K R Baumforth; D M Williams; M Lukesova; J Madarova; V Noskova; J Prochazkova; D Lowe; Z Kolar; P G Murray; P N Nelson
Journal:  Mol Pathol       Date:  2000-06

3.  Circulating immune complexes of Hodgkin's disease contain an antigen that is present in Hodgkin and Reed-Sternberg cells.

Authors:  G Bepler; Q Y Zhen; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

4.  Immunopathology of non-Hodgkin lymphomas.

Authors:  H Huber; C Gattringer; W Knapp; H Stein
Journal:  Klin Wochenschr       Date:  1984-11-02

Review 5.  The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma.

Authors:  Nicholas Meti; Khashayar Esfahani; Nathalie A Johnson
Journal:  Cancers (Basel)       Date:  2018-06-15       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.